Literature DB >> 33035296

Innovations in Human Immunodeficiency Virus (HIV) Care Delivery During the Coronavirus Disease 2019 (COVID-19) Pandemic: Policies to Strengthen the Ending the Epidemic Initiative-A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.

Wendy S Armstrong1,2, Allison L Agwu3,4, Ernie-Paul Barrette5, Rachel Bender Ignacio6,7, Jennifer J Chang8, Jonathan A Colasanti1,2,9, Michelle Floris-Moore10, Marwan Haddad11, Lynsay MacLaren12, Andrea Weddle13.   

Abstract

The goal of the Ending the HIV Epidemic Initiative is to reduce new infections in the United States by 90% by 2030. Success will require fundamentally changing human immunodeficiency virus (HIV) prevention and care delivery to engage more persons with HIV and at risk of HIV in treatment. While the coronavirus disease 2019 (COVID-19) pandemic reduced in-person visits to care facilities and led to concern about interruptions in care, it also accelerated growth of alternative options, bolstered by additional funding support. These included the use of telehealth, medication delivery to the home, and increased flexibility facilitating access to Ryan White HIV/AIDS Program services. While the outcomes of these programs must be studied, many have improved accessibility during the pandemic. As the pandemic wanes, long-term policy changes are needed to preserve these options for those who benefit from them. These new care paradigms may provide a roadmap for progress for those with other chronic health issues as well.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; Ryan White HIV/AIDS Program; antiretroviral therapy; pre-exposure prophylaxis; telehealth

Year:  2021        PMID: 33035296      PMCID: PMC7665349          DOI: 10.1093/cid/ciaa1532

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

1.  Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States.

Authors:  Rachel A Bender Ignacio; Adrienne E Shapiro; Robin M Nance; Bridget M Whitney; Joseph A C Delaney; Laura Bamford; Darcy Wooten; Maile Y Karris; William C Mathews; Hyang Nina Kim; Jeanne Keruly; Greer Burkholder; Sonia Napravnik; Kenneth H Mayer; Jeffrey Jacobson; Michael Saag; Richard D Moore; Joseph J Eron; Amanda L Willig; Katerina A Christopoulos; Jeffrey Martin; Peter W Hunt; Heidi M Crane; Mari M Kitahata; Edward R Cachay
Journal:  AIDS       Date:  2022-05-06       Impact factor: 4.632

2.  Patient Experiences with Telemedicine for HIV Care During the First COVID-19 Wave in Atlanta, Georgia.

Authors:  Karla I Galaviz; N Sarita Shah; Mariana Gutierrez; Lauren F Collins; Cecile D Lahiri; Caitlin A Moran; Brittany Szabo; Jeri Sumitani; Jeselyn Rhodes; Vincent C Marconi; Minh Ly Nguyen; Valeria D Cantos; Wendy S Armstrong; Jonathan A Colasanti
Journal:  AIDS Res Hum Retroviruses       Date:  2021-11-29       Impact factor: 1.723

3.  Characterization of the Population Affected by the 6-Month Recertification Criterion of the Ryan White HIV/AIDS Program's AIDS Drug Assistance Program in Washington State, 2017-2019.

Authors:  Steven Erly; Christine M Khosropour; Anjum Hajat; Monisha Sharma; Jen Reuer; Martha Grimm; Kelse Kwaiser; Julia C Dombrowski
Journal:  J Acquir Immune Defic Syndr       Date:  2022-01-01       Impact factor: 3.771

4.  Social, economic, and health effects of the COVID-19 pandemic on adolescents retained in or recently disengaged from HIV care in Kenya.

Authors:  Leslie A Enane; Edith Apondi; Josephine Aluoch; Giorgos Bakoyannis; Jayne Lewis Kulzer; Zachary Kwena; Rami Kantor; Ashley Chory; Adrian Gardner; Michael Scanlon; Suzanne Goodrich; Kara Wools-Kaloustian; Batya Elul; Rachel C Vreeman
Journal:  PLoS One       Date:  2021-09-10       Impact factor: 3.752

5.  HIV Preexposure Prophylaxis in the Time of COVID-19: How a Robust and Responsive HIV Preexposure Prophylaxis Intervention Can Avert Loss of HIV Prevention Coverage During a Global Pandemic.

Authors:  Parya Saberi; Kristin Ming; J Carlo Hojilla; Hyman M Scott; Torsten B Neilands
Journal:  J Acquir Immune Defic Syndr       Date:  2021-05-01       Impact factor: 3.771

6.  COVID-19 Pandemic, Pre-exposure Prophylaxis (PrEP) Care, and HIV/STI Testing Among Patients Receiving Care in Three HIV Epidemic Priority States.

Authors:  Brandon J Hill; Brie Anderson; Li Lock
Journal:  AIDS Behav       Date:  2021-02-18

7.  Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis.

Authors:  Dominik Stelzle; Peter Godfrey-Faussett; Chuan Jia; Obreniokibo Amiesimaka; Mary Mahy; Delivette Castor; Ioannis Hodges-Mameletzis; Lastone Chitembo; Rachel Baggaley; Shona Dalal
Journal:  PLoS Med       Date:  2021-01-11       Impact factor: 11.069

Review 8.  HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies.

Authors:  Ronnie M Gravett; Jeanne M Marrazzo
Journal:  Curr HIV/AIDS Rep       Date:  2021-06-08       Impact factor: 5.071

Review 9.  The Impact of COVID-19 on HIV Care Provided via Telemedicine-Past, Present, and Future.

Authors:  Jehan Z Budak; John D Scott; Shireesha Dhanireddy; Brian R Wood
Journal:  Curr HIV/AIDS Rep       Date:  2021-02-22       Impact factor: 5.071

10.  Telehealth for HIV Care Services in South Carolina: Utilization, Barriers, and Promotion Strategies During the COVID-19 Pandemic.

Authors:  Valerie Yelverton; Shan Qiao; Sharon Weissman; Bankole Olatosi; Xiaoming Li
Journal:  AIDS Behav       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.